Who is sponsoring NCT02642900?

NCT02642900 is sponsored by University of Sao Paulo.

What condition does NCT02642900 study?

NCT02642900 studies Photochemotherapy Reaction.

What drugs are being tested in NCT02642900?

Interventions: Photodynamic Therapy, Nystatin 100.000 units.

What is the status of NCT02642900?

NCT02642900 is currently COMPLETED.

Last reviewed 2015-12-25 · How we verify

Photodynamic Therapy Against Candida Spp. in Complete Denture Wearers: a Randomized Clinical Trial

NCT02642900 Phase 4 COMPLETED

Candida albicans is the most prevalent species in denture-related stomatitis (DS). There are several treatment options for this condition, including the use of antifungal agents such as nystatin and miconazole. The side effects and the increasing number of resistant species caused by the use of these drugs encourage the development of alternative therapies. Photodynamic Therapy (PDT) has been used as a promising treatment of stomatitis. In this randomized clinical trial, the effectiveness of PDT was evaluated. Patients in this study were allocated to two groups. One group was treated with nystatin, and the other group was treated with PDT.

Details

Lead sponsor	University of Sao Paulo
Phase	Phase 4
Status	COMPLETED
Enrolment	22
Start date	2009-07
Completion	2011-07

Conditions

Photochemotherapy Reaction

Interventions

Photodynamic Therapy
Nystatin 100.000 units

Primary outcomes

Treatment evolution of participants with Candida-related denture stomatitis, treated with PDT or Nystatin, by numbers of colony forming units per milliliter (cfu/mL) recovered from the palatal mucosa, from baseline to end of treatment — through study completion, an average of 45 days

Countries

Brazil